Philip Vernon

1.3k total citations
14 papers, 1.1k citations indexed

About

Philip Vernon is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Philip Vernon has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Philip Vernon's work include Autophagy in Disease and Therapy (5 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Immune Response and Inflammation (3 papers). Philip Vernon is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Immune Response and Inflammation (3 papers). Philip Vernon collaborates with scholars based in United States and China. Philip Vernon's co-authors include Daolin Tang, Rui Kang, Yan Yu, Michael T. Lotze, Herbert J. Zeh, Jiangdong Ni, Jun Huang, Kristen M. Livesey, Lizhi Cao and Ke Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Philip Vernon

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Vernon United States 10 574 418 277 262 238 14 1.1k
Nicole E. Schapiro United States 8 452 0.8× 260 0.6× 130 0.5× 479 1.8× 409 1.7× 11 1.1k
Liangchun Yang China 16 1.1k 2.0× 372 0.9× 616 2.2× 172 0.7× 550 2.3× 36 2.0k
Yumi Takiyama Japan 21 584 1.0× 145 0.3× 251 0.9× 77 0.3× 151 0.6× 48 1.4k
Hanning You United States 14 494 0.9× 101 0.2× 159 0.6× 84 0.3× 189 0.8× 18 1.1k
Atul Sahai United States 21 702 1.2× 455 1.1× 229 0.8× 92 0.4× 78 0.3× 46 1.6k
Manuela Indelicato Italy 13 316 0.6× 154 0.4× 211 0.8× 46 0.2× 114 0.5× 17 828
Vincent W.S. Liu Hong Kong 22 1.1k 2.0× 345 0.8× 408 1.5× 115 0.4× 89 0.4× 31 1.7k
Vivian Franklin Canada 14 537 0.9× 360 0.9× 178 0.6× 25 0.1× 173 0.7× 16 1.2k
Michaela Artwohl Austria 18 448 0.8× 217 0.5× 134 0.5× 37 0.1× 163 0.7× 23 1.0k
Olga A. Mareninova United States 22 425 0.7× 648 1.6× 86 0.3× 41 0.2× 392 1.6× 42 2.0k

Countries citing papers authored by Philip Vernon

Since Specialization
Citations

This map shows the geographic impact of Philip Vernon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Vernon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Vernon more than expected).

Fields of papers citing papers by Philip Vernon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Vernon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Vernon. The network helps show where Philip Vernon may publish in the future.

Co-authorship network of co-authors of Philip Vernon

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Vernon. A scholar is included among the top collaborators of Philip Vernon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Vernon. Philip Vernon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Sheppard, Forest R., Antoni R. Macko, Jacob Glaser, et al.. (2017). Nonhuman Primate (Rhesus Macaque) Models of Severe Pressure-Targeted Hemorrhagic and Polytraumatic Hemorrhagic Shock. Shock. 49(2). 174–186. 20 indexed citations
3.
4.
Vernon, Philip, et al.. (2015). Rapid Detection of Neutrophil Oxidative Burst Capacity is Predictive of Whole Blood Cytokine Responses. PLoS ONE. 10(12). e0146105–e0146105. 8 indexed citations
5.
Leibowitz, Brian J., Wei Qiu, Fangdong Zou, et al.. (2014). BID mediates selective killing of APC-deficient cells in intestinal tumor suppression by nonsteroidal antiinflammatory drugs. Proceedings of the National Academy of Sciences. 111(46). 16520–16525. 24 indexed citations
6.
Vernon, Philip, Herbert J. Zeh, & Michael T. Lotze. (2013). The myeloid response to pancreatic carcinogenesis is regulated by the receptor for advanced glycation end-products. OncoImmunology. 2(5). e24184–e24184. 9 indexed citations
7.
Livesey, Kristen M., Rui Kang, Philip Vernon, et al.. (2012). p53/HMGB1 Complexes Regulate Autophagy and Apoptosis. Cancer Research. 72(8). 1996–2005. 220 indexed citations
8.
Vernon, Philip & Daolin Tang. (2012). Eat-Me: Autophagy, Phagocytosis, and Reactive Oxygen Species Signaling. Antioxidants and Redox Signaling. 18(6). 677–691. 133 indexed citations
9.
Huang, Jun, Ke Liu, Yan Yu, et al.. (2012). Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy. 8(2). 275–277. 91 indexed citations
10.
Yu, Yan, Lei Yang, Ming Zhao, et al.. (2012). Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells. Leukemia. 26(8). 1752–1760. 172 indexed citations
11.
Kang, Rui, Tara Loux, Daolin Tang, et al.. (2012). The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia. Proceedings of the National Academy of Sciences. 109(18). 7031–7036. 142 indexed citations
12.
Vernon, Philip, Tara Loux, Nicole E. Schapiro, et al.. (2012). The Receptor for Advanced Glycation End Products Promotes Pancreatic Carcinogenesis and Accumulation of Myeloid-Derived Suppressor Cells. The Journal of Immunology. 190(3). 1372–1379. 50 indexed citations
13.
Huang, Jun, Jiangdong Ni, Ke Liu, et al.. (2011). HMGB1 Promotes Drug Resistance in Osteosarcoma. Cancer Research. 72(1). 230–238. 237 indexed citations
14.
Byrne, Colene & Philip Vernon. (1991). Validation of the Cause of Renal Failure of Patients in the Medicare End-Stage Renal Disease Program. American Journal of Kidney Diseases. 18(3). 375–378. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole E. Schapiro Breakdown of academic impact, for papers by Liangchun Yang Breakdown of academic impact, for papers by Yumi Takiyama Breakdown of academic impact, for papers by Hanning You Breakdown of academic impact, for papers by Atul Sahai Breakdown of academic impact, for papers by Manuela Indelicato Breakdown of academic impact, for papers by Vincent W.S. Liu Breakdown of academic impact, for papers by Vivian Franklin Breakdown of academic impact, for papers by Michaela Artwohl Breakdown of academic impact, for papers by Olga A. Mareninova
Rankless by CCL
2026